Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
Authors
Keywords
Melanomas, Article-level metrics, Prognosis, Lymph nodes, Negative staining, Metastasis, Multivariate analysis, Melanin
Journal
PLoS One
Volume 11, Issue 1, Pages e0147431
Publisher
Public Library of Science (PLoS)
Online
2016-01-22
DOI
10.1371/journal.pone.0147431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma
- (2015) Yi-Shuan Sheen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy
- (2015) Chiao-En Wu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- BRAF V600 mutations and pathological features in Japanese melanoma patients
- (2015) Naoya Yamazaki et al. MELANOMA RESEARCH
- The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
- (2014) A. Slominski et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development
- (2014) Lars Jønson et al. Cell Reports
- Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations
- (2013) Meriem Chraybi et al. HUMAN PATHOLOGY
- Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
- (2013) Anna A. Brożyna et al. HUMAN PATHOLOGY
- Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry
- (2013) Alan C. Geller et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis
- (2013) Leon Raskin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Unique prognostic factors in acral lentiginous melanoma
- (2012) Michael E. Egger et al. AMERICAN JOURNAL OF SURGERY
- Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns
- (2012) P.H. Youl et al. BRITISH JOURNAL OF DERMATOLOGY
- BRAF Mutations and KIT Aberrations and Their Clinicopathological Correlation in 202 Korean Melanomas
- (2012) Sun A. Jin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases
- (2011) Zhihong Chi et al. BMC CANCER
- Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma
- (2009) Ray-Hwang Yuan et al. ANNALS OF SURGICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- IMP-3 expression in melanocytic lesions
- (2009) Limin Yu et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Skin cancer trends among Asians living in Singapore from 1968 to 2006
- (2009) Judy Sng et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma
- (2008) Y.-M. Jeng et al. BRITISH JOURNAL OF SURGERY
- RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
- (2008) Yung-Ming Jeng et al. HEPATOLOGY
- Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
- (2008) Anna A. Brożyna et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells
- (2008) Andrzej Slominski et al. INTERNATIONAL JOURNAL OF CANCER
- IMP-3 is a novel progression marker in malignant melanoma
- (2008) Jennifer G Pryor et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search